# VeriSIM Life: Research, San Francisco, United States > VeriSIM Life: VeriSIM Life is a biotechnology company based in San Francisco, founded in 2017. Based in San Francisco, United States. Founded 2017. Source: https://millionrounds.com/startup/verisim-life (Millionrounds; every figure on the page links to its filing or article) United States · [Research startup](https://millionrounds.com/companies) # VeriSIM Life VeriSIM Life is a biotechnology company based in San Francisco, founded in 2017. Funding reported Last round: Series A Research San Francisco, United States Company summary - **Founded:** 2017 9 years old - **Team:** 18 11 to 50 people - **Funding reported:** $22M in dollars - **Last round:** Series A Jan 2022 How sure we are - ✓ **Listed** We know it exists and what it does - 2 **Funding reported** A company dataset reports a raise - 3 **Observed** A filing or a dated announcement confirms a round No round for VeriSIM Life has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology) ## About VeriSIM Life VeriSIM Life is a biotechnology company based in San Francisco, founded in 2017. The company focuses on enhancing drug development through artificial intelligence and machine learning, aiming to reduce reliance on animal testing by utilizing computational biosimulation. Its mission is to increase human life expectancy and personalize patient treatment by improving research and development decisions before preclinical trials. The flagship product, BIOiSIMTM, is an AI-driven virtual drug development engine that models drug interactions across multiple species. This platform provides predictive insights into drug efficacy and safety, enabling researchers to forecast clinical trial outcomes and streamline the drug discovery process. VeriSIM Life serves a diverse B2B audience, including pharmaceutical companies, biotech firms, and academic institutions, helping them to de-risk R&D decisions and accelerate the development of new therapies. The company has received recognition for its innovative approach, including being named the "Predictive Analytics Solution of the Year" by BioTech Breakthrough in 2022. ## What company datasets say VeriSIM Life raised Funding, as reported Reported in all **$22M** in dollars Rounds **4** Last round **Series A** Last round size **$15M** Last round date **Jan 2022** Investors listed **14** ## Founders and team From VeriSIM Life's own website: 1 founder, 9 on the team. **Jo Varshney** Founder & Chief Executive Officer - **Ed Parsley** Chief Medical Officer - **Sanjay Pothen** Chief Financial Officer - **Divesh Bhatt** Head of Biosimulations - **Emily Spady** Head of People Operations - **Peter Gissel** Staff Software Engineer - **Roshan Bhave** Senior AI/ML Solutions Architect - **Shawn Montgomery** Senior Software Engineer - **Weihao Qu** Scientific Data Engineer - **Yogesh Bundey** Senior ML Engineer II Advisers *Charles Goodwin* ## On 3 portfolio pages Investors who name them - [Amplify Partners](https://millionrounds.com/fund/amplify-partners) - [Stage Venture Partners](https://millionrounds.com/fund/stage-venture-partners) - [Nextwave X Partners](https://millionrounds.com/fund/nextwave-x-partners) Each firm lists VeriSIM Life on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source. ## The company, in detail What they build Known for health care biotechnology research patient outcome prediction time-to-market acceleration translational index technology enterprises generative ai for drug discovery information technology & services compound ranking virtual drug synthesis mechanistic modeling enterprise software drug discovery pipeline virtual screening of trillion compounds ai platform cost reduction in r&d Built with from their website Docker Google Tag Manager Amazon CloudFront Google Workspace CloudFlare Viewport Meta Hubspot Cloudflare WAF Babel Webflow Hosting +8 more AI Google Meet CloudFlare CDN Google Font API Articulate Storyline 3 Mobile Friendly Open Graph Amazon Route 53 - **Sector:** Research - **Industry code:** NAICS 541714, 513210, SIC 2834, 8731, 7372 - **Region:** California - **Revenue:** $2.2M a year, as listed - **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/verisim-life) ## Research in United States Startups like it - [**OpenAI** San Francisco · founded 2011 *Raised*](https://millionrounds.com/company/openai) - [**Retro Biosciences** Redwood City · founded 2021 *Raised*](https://millionrounds.com/company/retro-biosciences) - [**NewLimit** South San Francisco · founded 2022 *Raised*](https://millionrounds.com/company/newlimit) - [**Pathos** New York · founded 2022 *Raised*](https://millionrounds.com/company/pathos) - [**Colossal Biosciences** Dallas · founded 2021 *Raised*](https://millionrounds.com/company/colossal-biosciences) - [**Oratomic** South Pasadena *Raised*](https://millionrounds.com/company/oratomic) - [**Beeline Medicines** Stamford · founded 2025 *Raised*](https://millionrounds.com/company/beeline-medicines) - [**Element Biosciences** San Diego · founded 2017 *Raised*](https://millionrounds.com/company/element-biosciences) ## Is this your company? Add your raise, your deck and your story, and put VeriSIM Life in front of investors. Or tell us what we have wrong. [List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)